Propagative α-synuclein seeds as serum biomarkers for synucleinopathies - Nature Medicine

  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A modified seed aggregation assay detects minute amounts of serum α-synuclein seeds in individuals with Synucleinopathy, demonstrating high performance as a DiagnosticBiomarker.

This work was supported by the Japan Agency for Medical Research and Development ; the Multicenter Alliance for Brain Biomarkers ; Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; the Visionary Council on the Moonshot Research and Development Program ; grants-in-aid from the Research Committee of CNS Degenerative Disease, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labor, and Welfare Sciences Research Grants;...

Ayami Okuzumi, Taku Hatano, Shin-ichi Ueno, Yoko Imamichi-Tatano, Haruka Kimura, Yuanzhe Li, Manabu Funayama, Shinji Saiki, Daisuke Taniguchi, Taiji Tsunemi & Nobutaka HattoriGen MatsumotoShuko Nojiri Laboratory of Morphology and Image Analysis, Biomedical Research Core Facilities, Juntendo University Faculty of Medicine, Tokyo, JapanAkihide KondoTakeshi Fukuhara & Nobutaka HattoriTransversal Translational Medicine, Luxembourg Institute of Health , Strassen, LuxembourgLuxembourg National Center of Pathology , Laboratoire National de Santé ; Department of Cancer Research , Luxembourg Institute of Health ; Luxembourg Centre of Neuropathology , Luxembourg Centre for Systems Biomedicine...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 451. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance - Nature MedicineA single-cell analysis of tumor-infiltrating T cells from 16 cancer types identifies new T cell subsets and a stress response cell state enriched in tumors resistant to immunotherapy.
Source: NatureMedicine - 🏆 451. / 53 Read more »

In global approaches to dementia research, do not forget care - Nature MedicineIn global approaches to dementia research, do not forget care. Correspondence from fannymonnet and colleagues VUBrussel ugent
Source: NatureMedicine - 🏆 451. / 53 Read more »

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease - Nature MedicineCross-sectional and longitudinal analyses of tau pathology in preclinical Alzheimer’s disease reveal that tau tangles accumulate as a function of amyloid-β burden only in individuals positive for an astrocyte reactivity biomarker.
Source: NatureMedicine - 🏆 451. / 53 Read more »

Giorgio Armani Explains How He Left Medicine to Become a Designer in His New AutobiographyDiscover the man behind the fashion empire. Giorgio Armani's new autobiography, 'Per Amore', unveils the untold stories and memories that shaped his extraordinary career.
Source: RobbReport - 🏆 309. / 63 Read more »

Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation - Nature MedicineIn a study of two children with the metabolic condition D-2-hydroxyglutaric aciduria type II, the drug enasidenib, developed as a selective mutant IDH2 inhibitor for treatment of acute myeloid leukemia, had beneficial effects on cardiac and neurodevelopmental abnormalities, indicating the potential for the repurposing of this drug for this hereditary condition.
Source: NatureMedicine - 🏆 451. / 53 Read more »